The pharma company has announced that it had secured five product patents in China, Israel, Mexico, Singapore and Sri Lanka corresponding to its new chemical entities (NCEs) for the treatment of disorders associated with neurodegenerative diseases.
| Subscribe To Our Free Newsletter |
